Good news! Lukang Pharma Ranked on China Pharmaceutical Industry Top 100 List

Release time:2023-11-28

On Nov. 17-19, 2023 China Pharmaceutical Industry Development Conference was held in Beijing. During the 40th National Pharmaceutical Industry Information Conference & 2022 Top 100 China Pharmaceutical Industry Forum, the highly anticipated "2022 China Pharmaceutical Industry Top 100 List" was published, Lukang pharma entered the China Pharmaceutical Industry Top 100 List again.

This conference is jointly organized by the Ministry of Industry and Information Technology, Beijing Municipal Government, National Health Commission, State owned Assets Supervision and Administration Commission of the State Council, National Administration of Traditional Chinese Medicine, and National Medical Products Administration. The conference, with the theme of "Gathering Development Forces to Build a Solid Foundation for Health", focusing on the pharmaceutical industry, strengthening dialogue and communication, and building an industrial ecology. It shows the outstanding achievements and comprehensive capabilities of China's pharmaceutical industry in chemical medicine, traditional Chinese medicine, biological medicine, medical device, and builds a platform for communication and cooperation among all industry parties.

The China Pharmaceutical Industry Top 100 List is an authoritative industry list in China, and the ranked enterprises are all outstanding pharmaceutical industry, representing the forefront of industry development. Lukang pharma ranking on the China Pharmaceutical Industry Top 100 List indicates a comprehensive reflection of the company's overall capability, innovation ability and brand perception. 


Lukang pharma is "Top 10" leading enterprise in Shandong Province and a leading enterprise in the "Climbing Project" of Jining pharmaceutical industry. In recent years, Lukang pharma has adhered to the innovation driven strategy with R&D investment, implemented product structure adjustment and replaced old growth drivers with new ones. Lukang pharma re-established R&D system, enhanced R&D innovation capabilities, strengthened deep integration of industry, academia, and research led by enterprises orientation, to improve the scientific and technological achievement transformation and industrialization level. Lukang pharma ranking on the China Pharmaceutical Industry Top 100 List for several times fully demonstrates its significant achievements in innovation driven development, etc.

In future, Lukang pharma will persist in the innovative development concept and “Double driven” development strategy, making new breakthroughs in innovative drug R&D, biotechnology application, intelligent manufacturing, excellent performance management, and contributing to the Chinese medicine and human health business.